First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy ± radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma

References

• Jaffe E S, Harris N L, Stein H, Vardiman J W. World Health Organization Classification of Tumours, Pathology and Genetics: Tumours of Hematopoietic and Lymphoid Tissues. IARC, Lyon 2001
   Google Scholar
• Eichel B S, Harrison E G, Jr, Devine K D, Scanlon P W, Brown H A. Primary lymphoma of the nose including a relationship to lethal midline granuloma. Am J Surg 1966; 112: 597–605
   PubMed Web of Science ®Google Scholar
• McDonald T J, DeRemee R A, Harrison E G, Jr, Facer G W, Devine K D. The protean clinical features of polymorphic reticulosis (lethal midline granuloma). Laryngoscope 1976; 86: 936–945
   PubMed Web of Science ®Google Scholar
• Kassel S H, Echevarria R A, Guzzo F P. Midline malignant reticulosis (so-called lethal midline granuloma). Cancer 1969; 23: 920–935
   PubMed Web of Science ®Google Scholar
• Fechner R E, Lamppin D W. Midline malignant reticulosis. A clinicopathologic entity. Arch Otolaryngol 1972; 95: 467–476
   PubMed Web of Science ®Google Scholar
• Harris N L, Jaffe E S, Stein H, Banks P M, Chan J K, Cleary M L, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Chan J K, Sin V C, Wong K F, Ng C S, Tsang W Y, Chan C H, et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 1997; 89: 4501–4513
   PubMed Web of Science ®Google Scholar
• Kim G E, Cho J H, Yang W I, Chung E J, Suh C O, Park K R, et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment. J Clin Oncol 2000; 18: 54–63
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Krenacs L, Raffeld M. Classification of cytotoxic T-cell and natural killer cell lymphomas. Semin Hematol 2003; 40: 175–184
   PubMed Web of Science ®Google Scholar
• Ribrag V, Ell Hajj M, Janot F, Girinsky T, Domenge C, Schwaab G, et al. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia 2001; 15: 1123–1126
   PubMed Web of Science ®Google Scholar
• Chen H H, Fong L, Su I J, Ting L L, Hong R L, Leung H W, et al. Experience of radiotherapy in lethal midline granuloma with special emphasis on centrofacial T-cell lymphoma: a retrospective analysis covering a 34-year period. Radiother Oncol 1996; 38: 1–6
   PubMed Web of Science ®Google Scholar
• Sobrevilla-Calvo P, Meneses A, Alfaro P, Bares J P, Amador J, Reynoso E E. Radiotherapy compared to chemotherapy as initial treatment of angiocentric centrofacial lymphoma (polymorphic reticulosis). Acta Oncol 1993; 32: 69–72
   PubMed Web of Science ®Google Scholar
• Shikama N, Izuno I, Oguchi M, Gomi K, Sone S, Takei K, et al. Clinical stage IE primary lymphoma of the nasal cavity: radiation therapy and chemotherapy. Radiology 1997; 204: 467–470
   PubMed Web of Science ®Google Scholar
• You J Y, Chi K H, Yang M H, Chen C C, Ho C H, Chau W K, et al. Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma: a single institute survey in Taiwan. Ann Oncol 2004; 15: 618–625
   PubMed Web of Science ®Google Scholar
• Cheung M M, Chan J K, Lau W H, Foo W, Chan P T, Ng C S, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 1998; 16: 70–77
   PubMed Web of Science ®Google Scholar
• Logsdon M D, Ha C S, Kavadi V S, Cabanillas F, Hess M A, Cox J D. Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. Cancer 1997; 80: 477–488
   PubMed Web of Science ®Google Scholar
• Kim W S, Song S Y, Ahn Y C, Ko Y H, Baek C H, Kim D Y, et al. CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?. Ann Oncol 2001; 12: 349–352
   PubMed Web of Science ®Google Scholar
• Kim B S, Kim T Y, Kim C W, Kim J Y, Heo D S, Bang Y J, et al. Therapeutic outcome of extranodal NK/T-cell lymphoma initially treated with chemotherapy – result of chemotherapy in NK/T-cell lymphoma. Acta Oncol 2003; 42: 779–783
   PubMed Web of Science ®Google Scholar
• Imashuku S, Kuriyama K, Teramura T, Ishii E, Kinugawa N, Kato M, et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 2001; 19: 2665–2673
   PubMed Web of Science ®Google Scholar
• Aviles A, Neri N, Fernandez R, Calva A, Huerta-Guzman J, Nambo M J. Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy. Med Oncol 2003; 20: 13–17
   PubMed Web of Science ®Google Scholar
• Carbone P P, Kaplan H S, Musshoff K, Smithers D W, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31: 1860–1861
   PubMed Web of Science ®Google Scholar
• WHO. WHO Handbook for Reporting Results of Cancer Treatment. WHO, Geneva 1979
   Google Scholar
• Hryniuk W M, Good year M. The calculation of received dose intensity. J Clin Oncol 1990; 8: 1935–1937
   PubMed Web of Science ®Google Scholar
• Ko Y H, Kim C W, Park C S, Jang H K, Lee S S, Kim S H, et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 1998; 83: 806–812
   Google Scholar
• Kim K, Kim W S, Jung C W, Im Y H, Kang W K, Lee M H, et al. Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification. Eur J Cancer 2002; 38: 75–81
   PubMed Web of Science ®Google Scholar
• Cabanillas F, Hagemeister F B, Bodey G P, Freireich E J. IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. Blood 1982; 60: 693–697
   PubMed Web of Science ®Google Scholar
• Herbrecht R, Damonte J C, Dufour P, Maloisel F, Liu K L, Ortiz S, et al. Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen. Semin Oncol 1992; 19: 7–10
   PubMedGoogle Scholar
• Ichimura K, Kagami Y, Suzuki R, Kojima M, Yoshino T, Ohshima K, et al. Phenotypic analysis of peripheral T/NK cell lymphoma: study of 408 Japanese cases with special reference to their anatomical sites. Pathol Int 2003; 53: 333–344
   PubMed Web of Science ®Google Scholar